Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$105.09 USD
-1.38 (-1.30%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $105.05 -0.04 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | 4.71 |
EPS Last Quarter | 2.68 |
Last EPS Surprise | -35.27% |
ABR | 1.53 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 18.52 |
Next Year | 21.17 |
EPS (TTM) | 17.05 |
P/E (F1) | 5.75 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.01B | 1.04B | 4.05B | 4.39B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 1.05B | 1.06B | 4.11B | 4.65B |
Low Estimate | 984.00M | 1.02B | 4.00B | 4.16B |
Year ago Sales | 957.32M | 972.14M | 3.83B | 4.05B |
Year over Year Growth Est. | 5.21% | 7.39% | 5.63% | 8.41% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.71 | 5.21 | 18.52 | 21.17 |
# of Estimates | 12 | 10 | 11 | 12 |
Most Recent Consensus | 4.64 | 5.16 | 18.18 | 18.98 |
High Estimate | 5.21 | 5.37 | 19.20 | 23.85 |
Low Estimate | 4.15 | 4.87 | 18.15 | 17.40 |
Year ago EPS | 4.51 | 4.84 | 18.29 | 18.52 |
Year over Year Growth Est. | 4.43% | 7.64% | 1.26% | 14.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 3 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.71 | 5.21 | 18.52 | 21.17 |
7 Days Ago | 4.71 | 5.21 | 18.52 | 21.17 |
30 Days Ago | 4.71 | 5.21 | 18.52 | 21.17 |
60 Days Ago | 4.72 | 5.15 | 18.69 | 21.35 |
90 Days Ago | 4.67 | 4.92 | 18.97 | 21.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.71 | 5.21 | 18.52 | 22.02 |
Zacks Consensus Estimate | 4.71 | 5.21 | 18.52 | 21.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 4.03% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.68 | 5.02 | 4.84 | 4.51 | NA |
Estimate | 4.14 | 5.26 | 4.90 | 4.46 | NA |
Difference | -1.46 | -0.24 | -0.06 | 0.05 | -0.43 |
Surprise | -35.27% | -4.56% | -1.22% | 1.12% | -9.98% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more